Publications by authors named "Thomas Venables"

Claim this Profile
T
The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner.
Chuan Li, Yuan Ma, Luisa P Mori, Huiming Yang, Yi Wang, Thomas T Venables

Nucleic Acids Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state.
Luisa P Mori, Chuan Li, Thomas Venables, Andrew T McAuley, Adam J Getzler

Nucleic Acids Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paracrine FGF21 dynamically modulates mTOR signaling to regulate thymus function across the lifespan.
Sarah A Wedemeyer, Nicholas E Jones, Iwan G A Raza, Freedom M Green, Yangming Xiao, Thomas Venables

Nat Aging· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional and methylation outcomes of didehydro-cortistatin A use in HIV-1-infected CD4 T cells.
Luisa P Mori, Michael J Corley, Andrew T McAuley, Alina Pang, Thomas Venables

Life Sci Alliance· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mll1 pioneers histone H3K4me3 deposition and promotes formation of CD8 T stem cell memory.
Adam J Getzler, Megan A Frederick, Justin J Milner, Thomas Venables, Huitian Diao

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
Maria T Abreu, Julie M Davies, Maria A Quintero, Amber Delmas, Sophia Diaz, Thomas Venables

Inflamm Bowel Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia.
Matthew G Cyr, Maissa Mhibik, Junpeng Qi, Haiyong Peng, Jing Chang, Thomas Venables

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.
Patrycja K Thompson, Edward L Y Chen, Renée F de Pooter, Catherine Frelin, Walter K Vogel, Thomas Venables

J Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox regulation of age-associated defects in generation and maintenance of T cell self-tolerance and immunity to foreign antigens.
Allison K Hester, Manpreet K Semwal, Sergio Cepeda, Yangming Xiao, Meghan Rueda, Thomas Venables

Cell Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes in epithelial cell morphology control thymic organ size during atrophy and regeneration.
Thomas Venables, Ann V Griffith, Alice DeAraujo, Howard T Petrie

Nat Commun· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Associated Decline in Thymic B Cell Expression of Aire and Aire-Dependent Self-Antigens.
Sergio Cepeda, Carolina Cantu, Stephanie Orozco, Yangming Xiao, Zoe Brown, Thomas Venables

Cell Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Damage and Premature Thymus Aging Caused by Stromal Catalase Deficiency.
Ann V Griffith, Thomas Venables, Jianjun Shi, Andrew Farr, Holly van Remmen

Cell Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent degenerative changes in thymic organ function revealed by an inducible model of organ regrowth.
Ann V Griffith, Mohammad Fallahi, Thomas Venables, Howard T Petrie

Aging Cell· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months.
Nicholas J Talley, Thomas L Venables, Jonathan R B Green, David Armstrong, Kevin P J O'Kane

Eur J Gastroenterol Hepatol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis